Cargando…
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
BACKGROUND AND OBJECTIVE: Inhalational exposures are a known cause of interstitial lung disease (ILD), but little is understood about their prevalence across ILD subtypes and their relationship with pulmonary function and survival. METHODS: Patients with fibrotic ILD were identified from the multice...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296585/ https://www.ncbi.nlm.nih.gov/pubmed/35512793 http://dx.doi.org/10.1111/resp.14267 |
_version_ | 1784750302592761856 |
---|---|
author | Lee, Cathryn T. Strek, Mary E. Adegunsoye, Ayodeji Wong, Alyson W. Assayag, Deborah Cox, Gerard Fell, Charlene D. Fisher, Jolene H. Gershon, Andrea S. Halayko, Andrew J. Hambly, Nathan Khalil, Nasreen Kolb, Martin Lok, Stacey D. Manganas, Hélène Marcoux, Veronica Morisset, Julie Sadatsafavi, Mohsen Shapera, Shane To, Teresa Wilcox, Pearce Ryerson, Christopher J. Johannson, Kerri A. |
author_facet | Lee, Cathryn T. Strek, Mary E. Adegunsoye, Ayodeji Wong, Alyson W. Assayag, Deborah Cox, Gerard Fell, Charlene D. Fisher, Jolene H. Gershon, Andrea S. Halayko, Andrew J. Hambly, Nathan Khalil, Nasreen Kolb, Martin Lok, Stacey D. Manganas, Hélène Marcoux, Veronica Morisset, Julie Sadatsafavi, Mohsen Shapera, Shane To, Teresa Wilcox, Pearce Ryerson, Christopher J. Johannson, Kerri A. |
author_sort | Lee, Cathryn T. |
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: Inhalational exposures are a known cause of interstitial lung disease (ILD), but little is understood about their prevalence across ILD subtypes and their relationship with pulmonary function and survival. METHODS: Patients with fibrotic ILD were identified from the multicentre Canadian Registry for Pulmonary Fibrosis. Patients completed questionnaires regarding ILD‐related occupational and environmental exposures. The relationship between exposures and the outcomes of baseline age, gender, family history, pulmonary function and survival was analysed using linear and logistic regression models, linear mixed‐effect regression models and survival analysis using multivariable Cox proportional hazards along with the log‐rank test. RESULTS: There were 3820 patients included in this study, with 2385 (62%) having ILD‐related inhalational exposure. Exposed patients were younger, particularly in the idiopathic pulmonary fibrosis subgroup. Inhalational exposure was associated with male gender (adjusted OR 1.46, 95% CI 1.28–1.68, p < 0.001) and family history of pulmonary fibrosis (adjusted OR 1.73, 95% CI 1.40–2.15, p < 0.001). Patients with any inhalational exposure had improved transplant‐free survival (hazard ratio 0.81, 95% CI 0.71–0.92, p = 0.001); this effect persisted across diagnostic subtypes. The relationship between exposures and annual change in forced vital capacity varied by ILD subtype. CONCLUSION: Patients with fibrotic ILD report high prevalence of inhalational exposures across ILD subtypes. These exposures were associated with younger age at diagnosis, male gender and family history of pulmonary fibrosis. Identification of an inhalational exposure was associated with a survival benefit. These findings suggest that inhaled exposures may impact clinical outcomes in patients with ILD, and future work should characterize the mechanisms underlying these relationships. |
format | Online Article Text |
id | pubmed-9296585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-92965852022-10-14 Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis Lee, Cathryn T. Strek, Mary E. Adegunsoye, Ayodeji Wong, Alyson W. Assayag, Deborah Cox, Gerard Fell, Charlene D. Fisher, Jolene H. Gershon, Andrea S. Halayko, Andrew J. Hambly, Nathan Khalil, Nasreen Kolb, Martin Lok, Stacey D. Manganas, Hélène Marcoux, Veronica Morisset, Julie Sadatsafavi, Mohsen Shapera, Shane To, Teresa Wilcox, Pearce Ryerson, Christopher J. Johannson, Kerri A. Respirology ORIGINAL ARTICLES BACKGROUND AND OBJECTIVE: Inhalational exposures are a known cause of interstitial lung disease (ILD), but little is understood about their prevalence across ILD subtypes and their relationship with pulmonary function and survival. METHODS: Patients with fibrotic ILD were identified from the multicentre Canadian Registry for Pulmonary Fibrosis. Patients completed questionnaires regarding ILD‐related occupational and environmental exposures. The relationship between exposures and the outcomes of baseline age, gender, family history, pulmonary function and survival was analysed using linear and logistic regression models, linear mixed‐effect regression models and survival analysis using multivariable Cox proportional hazards along with the log‐rank test. RESULTS: There were 3820 patients included in this study, with 2385 (62%) having ILD‐related inhalational exposure. Exposed patients were younger, particularly in the idiopathic pulmonary fibrosis subgroup. Inhalational exposure was associated with male gender (adjusted OR 1.46, 95% CI 1.28–1.68, p < 0.001) and family history of pulmonary fibrosis (adjusted OR 1.73, 95% CI 1.40–2.15, p < 0.001). Patients with any inhalational exposure had improved transplant‐free survival (hazard ratio 0.81, 95% CI 0.71–0.92, p = 0.001); this effect persisted across diagnostic subtypes. The relationship between exposures and annual change in forced vital capacity varied by ILD subtype. CONCLUSION: Patients with fibrotic ILD report high prevalence of inhalational exposures across ILD subtypes. These exposures were associated with younger age at diagnosis, male gender and family history of pulmonary fibrosis. Identification of an inhalational exposure was associated with a survival benefit. These findings suggest that inhaled exposures may impact clinical outcomes in patients with ILD, and future work should characterize the mechanisms underlying these relationships. John Wiley & Sons, Ltd 2022-05-05 2022-08 /pmc/articles/PMC9296585/ /pubmed/35512793 http://dx.doi.org/10.1111/resp.14267 Text en © 2022 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | ORIGINAL ARTICLES Lee, Cathryn T. Strek, Mary E. Adegunsoye, Ayodeji Wong, Alyson W. Assayag, Deborah Cox, Gerard Fell, Charlene D. Fisher, Jolene H. Gershon, Andrea S. Halayko, Andrew J. Hambly, Nathan Khalil, Nasreen Kolb, Martin Lok, Stacey D. Manganas, Hélène Marcoux, Veronica Morisset, Julie Sadatsafavi, Mohsen Shapera, Shane To, Teresa Wilcox, Pearce Ryerson, Christopher J. Johannson, Kerri A. Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis |
title | Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
|
title_full | Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
|
title_fullStr | Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
|
title_full_unstemmed | Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
|
title_short | Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
|
title_sort | inhalational exposures in patients with fibrotic interstitial lung disease: presentation, pulmonary function and survival in the canadian registry for pulmonary fibrosis |
topic | ORIGINAL ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296585/ https://www.ncbi.nlm.nih.gov/pubmed/35512793 http://dx.doi.org/10.1111/resp.14267 |
work_keys_str_mv | AT leecathrynt inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT strekmarye inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT adegunsoyeayodeji inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT wongalysonw inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT assayagdeborah inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT coxgerard inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT fellcharlened inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT fisherjoleneh inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT gershonandreas inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT halaykoandrewj inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT hamblynathan inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT khalilnasreen inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT kolbmartin inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT lokstaceyd inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT manganashelene inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT marcouxveronica inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT morissetjulie inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT sadatsafavimohsen inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT shaperashane inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT toteresa inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT wilcoxpearce inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT ryersonchristopherj inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis AT johannsonkerria inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis |